Flagship Ventures Fund IV General Partner LLC Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Flagship Ventures Fund IV General Partner LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Flagship Ventures Fund IV General Partner LLC. Flagship Ventures Fund IV General Partner LLC is 10% Owner in Seres Therapeutics, Inc. ($MCRB) and 10% Owner in Axcella Health Inc. ($AXLA) and Director in Moderna, Inc. ($MRNA) and 10% Owner in Evelo Biosciences, Inc. ($EVLO) and 10% Owner in Rubius Therapeutics, Inc. ($RUBY) and Director in Rubius Therapeutics, Inc. ($RUBY) and 10% Owner in Kaleido Biosciences, Inc. ($KLDO) and Director in Kaleido Biosciences, Inc. ($KLDO) and 10% Owner in TransMedics Group, Inc. ($TMDX).

Latest Insider Trading Transactions of Flagship Ventures Fund IV General Partner LLC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AXLA, EVLO, KLDO, MRNA, RUBY, MCRB, TMDX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 23 2021	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	29.00	70,000	2,030,000	2,633,703	2.6 M to 2.6 M (+2.73 %)
Mar 23 2021	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	29.00	70,000	2,030,000	5,859,414	5.8 M to 5.9 M (+1.21 %)
Mar 23 2021	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	29.00	70,000	2,030,000	15,393,593	15.3 M to 15.4 M (+0.46 %)
Feb 10 2021	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	11.50	71,667	824,171	738,333	666.7 K to 738.3 K (+10.75 %)
Feb 10 2021	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	11.50	71,667	824,171	2,982,639	2.9 M to 3 M (+2.46 %)
Feb 10 2021	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	11.50	71,666	824,159	1,685,444	1.6 M to 1.7 M (+4.44 %)
Feb 04 2021	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	15.00	46,429	696,435	4,125,461	4.1 M to 4.1 M (+1.14 %)
Feb 04 2021	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	15.00	37,143	557,145	1,370,476	1.3 M to 1.4 M (+2.79 %)
Feb 04 2021	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	15.00	9,285	139,275	791,529	782.2 K to 791.5 K (+1.19 %)
Feb 04 2021	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	15.00	37,143	557,145	3,207,312	3.2 M to 3.2 M (+1.17 %)
Nov 25 2020	MCRB	Seres Therapeutics ...	Flagship Ventures Fund IV Gene ...	10% Owner	Sell	J	0.00	43,154	0	0	43.2 K to 0 (-100.00 %)
Nov 25 2020	MCRB	Seres Therapeutics ...	Flagship Ventures Fund IV Gene ...	10% Owner	Sell	J	0.00	1,481,481	0	2,962,963	4.4 M to 3 M (-33.33 %)
Nov 25 2020	MCRB	Seres Therapeutics ...	Flagship Ventures Fund IV Gene ...	10% Owner	Sell	J	0.00	1,186,310	0	3,258,134	4.4 M to 3.3 M (-26.69 %)
Nov 25 2020	MCRB	Seres Therapeutics ...	Flagship Ventures Fund IV Gene ...	10% Owner	Sell	J	0.00	966,234	0	0	966.2 K to 0 (-100.00 %)
Nov 25 2020	MCRB	Seres Therapeutics ...	Flagship Ventures Fund IV Gene ...	10% Owner	Sell	J	0.00	642,180	0	1,283,282	1.9 M to 1.3 M (-33.35 %)
Nov 25 2020	MCRB	Seres Therapeutics ...	Flagship Ventures Fund IV Gene ...	10% Owner	Sell	J	0.00	3,587,820	0	4,434,600	8 M to 4.4 M (-44.72 %)
Aug 19 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	J	0.00	2,053,049	0	0	2.1 M to 0 (-100.00 %)
Aug 19 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	J	0.00	1,449,190	0	4,971,576	6.4 M to 5 M (-22.57 %)
Aug 19 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	J	0.00	7,550,810	0	14,435,589	22 M to 14.4 M (-34.34 %)
Jul 01 2020	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	3.75	1,666,667	6,250,001	4,079,032	2.4 M to 4.1 M (+69.09 %)
Jul 01 2020	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	3.75	1,333,333	4,999,999	1,333,333	0 to 1.3 M
Jul 01 2020	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	3.75	333,333	1,249,999	782,244	448.9 K to 782.2 K (+74.25 %)
Jul 01 2020	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	3.75	1,333,333	4,999,999	3,170,169	1.8 M to 3.2 M (+72.59 %)
Jun 08 2020	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	7.50	666,666	4,999,995	666,666	0 to 666.7 K
Jun 08 2020	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	7.50	666,667	5,000,003	2,910,972	2.2 M to 2.9 M (+29.70 %)
Jun 08 2020	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	7.50	666,667	5,000,003	1,613,778	947.1 K to 1.6 M (+70.39 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	70.18	10,746	754,113	6,420,766	6.4 M to 6.4 M (-0.17 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	69.45	69,254	4,809,448	6,431,512	6.5 M to 6.4 M (-1.07 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	70.18	56,406	3,958,353	21,986,399	22 M to 22 M (-0.26 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	69.45	363,594	25,250,331	22,042,805	22.4 M to 22 M (-1.62 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	72.44	367	26,584	6,500,766	6.5 M to 6.5 M (-0.01 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	71.51	2,551	182,433	6,501,133	6.5 M to 6.5 M (-0.04 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	70.46	3,900	274,780	6,503,684	6.5 M to 6.5 M (-0.06 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	68.81	7,443	512,185	6,507,584	6.5 M to 6.5 M (-0.11 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	67.15	23,199	1,557,822	6,515,027	6.5 M to 6.5 M (-0.35 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	65.77	42,540	2,797,690	6,538,226	6.6 M to 6.5 M (-0.65 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	72.44	1,933	140,017	22,406,399	22.4 M to 22.4 M (-0.01 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	71.51	13,408	958,861	22,408,332	22.4 M to 22.4 M (-0.06 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	70.46	20,492	1,443,793	22,421,740	22.4 M to 22.4 M (-0.09 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	68.81	39,082	2,689,404	22,442,232	22.5 M to 22.4 M (-0.17 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	67.15	121,771	8,176,971	22,481,314	22.6 M to 22.5 M (-0.54 %)
May 26 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	65.77	223,314	14,686,491	22,603,085	22.8 M to 22.6 M (-0.98 %)
May 20 2020	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	4.75	1,900,000	9,025,000	2,886,023	986 K to 2.9 M (+192.69 %)
May 20 2020	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	4.75	380,000	1,805,000	1,056,752	676.8 K to 1.1 M (+56.15 %)
May 20 2020	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	4.75	1,520,000	7,220,000	4,808,780	3.3 M to 4.8 M (+46.22 %)
May 13 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	J	0.00	2,281,179	0	0	2.3 M to 0 (-100.00 %)
May 13 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	J	0.00	1,610,000	0	6,580,766	8.2 M to 6.6 M (-19.66 %)
May 13 2020	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	J	0.00	8,390,000	0	22,826,399	31.2 M to 22.8 M (-26.88 %)
Dec 11 2019	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	18.65	38,366	715,710	8,190,766	8.2 M to 8.2 M (-0.47 %)
Dec 11 2019	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	18.65	199,935	3,729,747	31,216,399	31.4 M to 31.2 M (-0.64 %)
Dec 11 2019	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	18.96	4,092	77,579	8,229,132	8.2 M to 8.2 M (-0.05 %)
Dec 11 2019	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	18.96	21,325	404,292	31,416,334	31.4 M to 31.4 M (-0.07 %)
Dec 11 2019	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	18.99	27,714	526,408	8,233,224	8.3 M to 8.2 M (-0.34 %)
Dec 11 2019	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	S	18.99	144,423	2,743,199	31,437,659	31.6 M to 31.4 M (-0.46 %)
Dec 11 2019	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	J	0.00	1,735,720	0	0	1.7 M to 0 (-100.00 %)
Dec 11 2019	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	J	0.00	1,207,658	0	8,260,938	9.5 M to 8.3 M (-12.75 %)
Dec 11 2019	MRNA	Moderna, Inc.	Flagship Ventures Fund IV Gene ...	Director	Sell	J	0.00	6,292,342	0	31,582,082	37.9 M to 31.6 M (-16.61 %)
Oct 31 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Sell	J	0.00	248,379	0	0	248.4 K to 0 (-100.00 %)
Oct 31 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Sell	J	0.00	61,537	0	0	61.5 K to 0 (-100.00 %)
Oct 31 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Sell	J	0.00	1,061,102	0	0	1.1 M to 0 (-100.00 %)
Oct 31 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Sell	J	0.00	1,469,173	0	0	1.5 M to 0 (-100.00 %)
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	895,255	0	0
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	89,525	0	0
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	358,102	0	0
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	151,643	0	0
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	617,914	0	0
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	222,506	0	0
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	1,005,413	0	0
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	928,074	0	0
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	386,697	0	0
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	4,153,847	0	0
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	1,384,615	0	0
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	20.00	500,000	10,000,000	986,023	486 K to 986 K (+102.88 %)
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	486,023	0	486,023	0 to 486 K
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	48,602	0	676,752	628.2 K to 676.8 K (+7.74 %)
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	194,409	0	3,288,780	3.1 M to 3.3 M (+6.28 %)
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	82,324	0	628,150	545.8 K to 628.2 K (+15.08 %)
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	335,457	0	3,094,371	2.8 M to 3.1 M (+12.16 %)
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	120,795	0	1,761,029	1.6 M to 1.8 M (+7.36 %)
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	545,826	0	545,826	0 to 545.8 K
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	503,840	0	2,758,914	2.3 M to 2.8 M (+22.34 %)
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	209,933	0	1,640,234	1.4 M to 1.6 M (+14.68 %)
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	2,255,074	0	2,255,074	0 to 2.3 M
May 15 2019	AXLA	Axcella Health Inc ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	751,691	0	1,430,301	678.6 K to 1.4 M (+110.77 %)
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	1,682,665	0	0
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	450,958	0	0
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	600,000	0	0
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	1,257,465	0	0
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	992,110	0	0
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	1,400,000	0	0
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	2,000,000	0	0
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	792,366	0	1,061,102	268.7 K to 1.1 M (+294.85 %)
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	1,254,888	0	1,469,173	214.3 K to 1.5 M (+585.62 %)
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	J	0.00	268,736	0	268,736	0 to 268.7 K
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Sell	J	0.00	940,579	0	0	940.6 K to 0 (-100.00 %)
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	J	0.00	214,285	0	214,285	0 to 214.3 K
May 06 2019	TMDX	TransMedics Group, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Sell	J	0.00	750,000	0	0	750 K to 0 (-100.00 %)
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	562,407	0	0
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	347,173	0	0
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	1,331,816	0	0
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	281,203	0	947,111	665.9 K to 947.1 K (+42.23 %)
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	173,586	0	216,451	42.9 K to 216.5 K (+404.96 %)
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	665,908	0	665,908	0 to 665.9 K
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	562,407	0	0
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	347,173	0	0
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	1,331,816	0	0
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	281,203	0	947,111	665.9 K to 947.1 K (+42.23 %)
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	173,586	0	216,451	42.9 K to 216.5 K (+404.96 %)
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	665,908	0	665,908	0 to 665.9 K
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	781,860	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	195,466	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	195,466	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	1,781,843	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	593,948	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	593,948	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	5,000,000	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	5,000,000	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	3,830,402	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	15,323,593	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	781,860	0	2,563,703	1.8 M to 2.6 M (+43.88 %)
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	195,466	0	5,789,414	5.6 M to 5.8 M (+3.49 %)
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	195,466	0	5,789,414	5.6 M to 5.8 M (+3.49 %)
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	1,781,843	0	1,781,843	0 to 1.8 M
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	593,948	0	5,593,948	5 M to 5.6 M (+11.88 %)
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	593,948	0	5,593,948	5 M to 5.6 M (+11.88 %)
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	5,000,000	0	5,000,000	0 to 5 M
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	5,000,000	0	5,000,000	0 to 5 M
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	3,830,402	0	3,830,402	0 to 3.8 M
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	15,323,593	0	15,323,593	0 to 15.3 M
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	4,643,963	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	18,611,110	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	8,333,000	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	5,416,667	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	10,102,055	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	12,536,945	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	16.00	281,250	4,500,000	18,233,403	18 M to 18.2 M (+1.57 %)
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	14,622,143	0	17,952,153	3.3 M to 18 M (+439.10 %)
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	4,643,963	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	18,611,110	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	8,333,000	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	5,416,667	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	10,102,055	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	12,536,945	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	16.00	281,250	4,500,000	18,233,403	18 M to 18.2 M (+1.57 %)
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	14,622,143	0	17,952,153	3.3 M to 18 M (+439.10 %)

Page: 1